Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRH and mast cells in stress-induced intestinal permeability in healthy volunteers
2012-001263-73Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Apr 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of sodium cromoglycate and corticorelin ovine triflutate in intestinal hyperpermeability, sponsored by UZ Leuven. Primary endpoint: Prevention of stress-induced intestinal permeability changes by cromoglicic acid. Started Apr 2012; status: completed.
02
Drugs
sodium cromoglycatecorticorelin ovine triflutate
03
Conditions
intestinal hyperpermeability
Beyond the preview
Go deeper on 2012-001263-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001263-73.